Composition for targeted cell treatment

Details Composition for targeted cell treatment Composition for targeted cell treatment

2006-09-26

2006-09-26

Nickol, G. (Department: 1642)

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

C424S001110, C424S198100

Reexamination Certificate

active

07112328

ABSTRACT:
Compositions, vaccines and kits for cancer immunotherapy are described. The compositions, vaccines and kits may include transfer factor. The compositions, vaccines and kits also include modified monoclonal antibodies directed to cancer cells, other specific cancer receptor agonists, or viruses which infect cancer cells. The invention is also directed to methods of cancer immunotherapy using the compositions and vaccines of the invention.

REFERENCES:
Gura (Science, v278, 1997, pp. 1041-1042).
Weiner L.M., Seminars Oncology, vol. 26, No. 4, Suppl 12, pp. 41-50, 1999.
Kranz et al (PNAS USA Sep. 1995; 92:9057-9061).

Affiliated with

Also associated with

Rating

Composition for targeted cell treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for targeted cell treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for targeted cell treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3567262